Oncternal Therapeutics, Inc.(ONCT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ONCT Oncternal Therapeutics, Inc.

已收盘 11-22 16:00:00 EST

1.14

-0.02

-1.72%

盘后1.14

+0.000.00%

16:00 EST

最高1.16	最低1.10	成交量2.20万
今开1.11	昨收1.16	日振幅4.74%
总市值337.40万	流通市值308.53万	总股本295.96万
成交额2.46万	换手率0.81%	流通股本270.64万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ONCT","market":"US","secType":"STK","nameCN":"Oncternal Therapeutics, Inc.","latestPrice":1.14,"timestamp":1732309200000,"preClose":1.16,"halted":0,"volume":22020,"hourTrading":{"tag":"盘后","latestPrice":1.14,"preClose":1.14,"latestTime":"16:00 EST","volume":24,"amount":27.36,"timestamp":1732309201075},"delay":0,"floatShares":2706360,"shares":2959645,"eps":-11.691605,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.02,"latestTime":"11-22 16:00:00 EST","open":1.11,"high":1.155,"low":1.1,"amount":24557.985564,"amplitude":0.047414,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.691605,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1075784400000,"adjPreClose":1.16,"preHourTrading":{"tag":"盘前","latestPrice":1.16,"preClose":1.16,"latestTime":"09:28 EST","volume":1,"amount":1.16,"timestamp":1732285680059},"postHourTrading":{"tag":"盘后","latestPrice":1.14,"preClose":1.14,"latestTime":"16:00 EST","volume":24,"amount":27.36,"timestamp":1732309201075},"volumeRatio":0.608533,"impliedVol":3.9363,"impliedVolPercentile":0.9714},"requestUrl":"/m/hq/s/ONCT","defaultTab":"news","newsList":[{"id":"2485623072","title":"Oncternal Therapeutics, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485623072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485623072?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:43","pubTimestamp":1732286625,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时43分，Oncternal Therapeutics, Inc.股票出现异动，股价大幅下跌5.17%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Virpax Pharmaceuticals, Inc.、Exicure, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为897.54%、80.71%、68.93%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为44.82%、33.24%、30.69%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224345971a81b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224345971a81b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ONCT"],"gpt_icon":0},{"id":"2485085127","title":"Oncternal Therapeutics, Inc.盘中异动 大幅上涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485085127","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485085127?lang=zh_cn&edition=full","pubTime":"2024-11-21 03:55","pubTimestamp":1732132541,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日03时55分，Oncternal Therapeutics, Inc.股票出现波动，股价急速拉升5.56%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Forte Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Exicure, Inc.涨幅较大，Forte Biosciences, Inc.、Silexion Therapeutics Corp、Exicure, Inc.较为活跃，换手率分别为1888.00%、1336.15%、1015.27%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Exicure, Inc.，振幅分别为185.64%、169.09%、136.94%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121035541abd2bb52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121035541abd2bb52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0},{"id":"2484609184","title":"Oncternal Therapeutics, Inc.盘中异动 急速跳水5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484609184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484609184?lang=zh_cn&edition=full","pubTime":"2024-11-19 01:08","pubTimestamp":1731949705,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日01时08分，Oncternal Therapeutics, Inc.股票出现异动，股价快速跳水5.26%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Hcw Biologics Inc.、Geovax Labs Inc C/Wts 29/09/2025、冠科美博涨幅较大，Hcw Biologics Inc.、Tharimmune, Inc.、冠科美博较为活跃，换手率分别为1029.64%、564.36%、553.80%，振幅较大的相关个股有Hcw Biologics Inc.、Apollomics Inc C/Wts 01/04/2028 、Geovax Labs Inc C/Wts 29/09/2025，振幅分别为397.15%、129.51%、91.09%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119010825a2436e96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119010825a2436e96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0},{"id":"2483822918","title":"Oncternal Therapeutics, Inc.盘中异动 股价大跌6.61%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483822918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483822918?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:02","pubTimestamp":1731510165,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日23时02分，Oncternal Therapeutics, Inc.股票出现波动，股价快速下跌6.61%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Kairos Pharma, Ltd.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为362.27%、217.64%、92.43%，振幅较大的相关个股有Lexeo Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Kairos Pharma, Ltd.，振幅分别为44.21%、36.31%、28.72%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113230245971a64f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113230245971a64f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ONCT","BK4139"],"gpt_icon":0},{"id":"2481101087","title":"Oncternal Therapeutics, Inc.盘中异动 急速下跌5.11%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101087?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:36","pubTimestamp":1731076594,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时36分，Oncternal Therapeutics, Inc.股票出现异动，股价大幅下跌5.11%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Fortrea Holdings Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Poseida Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为413.48%、21.72%、16.17%，振幅较大的相关个股有Cardiff Oncology, Inc.、Rigel Pharmaceuticals, Inc.、Anebulo Pharmaceuticals, Inc.，振幅分别为18.09%、16.52%、14.96%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822363598e417a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822363598e417a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ONCT","BK4139"],"gpt_icon":0},{"id":"2481604720","title":"Oncternal Therapeutics Inc    预计每股亏损 3.19 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481604720","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481604720?lang=zh_cn&edition=full","pubTime":"2024-11-06 21:54","pubTimestamp":1730901295,"startTime":"0","endTime":"0","summary":"   * Oncternal Therapeutics Inc    预计将在11月7日公布截至2024年9月30日的业绩报告时显示季度收入下降(预计)    * 根据LSEG的数据，2位分析师的平均预期显示，这家总部位于加利福尼亚州圣地亚哥的公司的营收预计将从去年同期的17.9万美元下降23.2%，至13.75万美元。* LSEG 的分析师平均预计 Oncternal Therapeutics Inc 每股亏损 3.19 美元。* 华尔街对 Oncternal Therapeutics Inc 的 12 个月目标价中位数为 20.50 美元，高于其最新收盘价 1.62 美元。11月6日 - 本摘要于北京时间 11 月 6 日 13:54 机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONCT","LENZ"],"gpt_icon":0},{"id":"2480943050","title":"Oncternal Therapeutics, Inc.盘中异动 快速跳水5.25%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480943050","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480943050?lang=zh_cn&edition=full","pubTime":"2024-11-01 02:40","pubTimestamp":1730400040,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日02时40分，Oncternal Therapeutics, Inc.股票出现波动，股价大幅跳水5.25%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.32%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Aditxt, Inc.、Evogene Ltd.、Gri Bio, Inc.较为活跃，换手率分别为273.02%、242.55%、196.92%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Vaccinex, Inc.、Promis Neurosciences Inc.，振幅分别为80.77%、47.15%、46.79%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101024040ab8ceb35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101024040ab8ceb35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ONCT"],"gpt_icon":0},{"id":"2479238364","title":"Oncternal Therapeutics, Inc.盘中异动 大幅上涨5.23%报1.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479238364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479238364?lang=zh_cn&edition=full","pubTime":"2024-10-29 23:28","pubTimestamp":1730215716,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日23时28分，Oncternal Therapeutics, Inc.股票出现波动，股价大幅拉升5.23%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029232836ab7f63d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029232836ab7f63d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ONCT","BK4139"],"gpt_icon":0},{"id":"2477563168","title":"Oncternal Therapeutics, Inc.盘中异动 早盘大幅下跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477563168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477563168?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:41","pubTimestamp":1729777266,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时41分，Oncternal Therapeutics, Inc.股票出现异动，股价大幅跳水5.52%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Dbv Technologies、Cns Pharmaceuticals, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃，换手率分别为204.65%、107.56%、42.22%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Gt Biopharma, Inc.，振幅分别为45.75%、36.67%、17.80%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024214107ab70a7db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024214107ab70a7db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ONCT","BK4139"],"gpt_icon":0},{"id":"2477538025","title":"Oncternal Therapeutics, Inc.盘中异动 急速上涨5.73%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477538025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477538025?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:37","pubTimestamp":1729690672,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时37分，Oncternal Therapeutics, Inc.股票出现异动，股价快速上涨5.73%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Cns Pharmaceuticals, Inc.、Virax Biolabs Group Limited、Tevogen Bio Holdings Inc.涨幅较大，Virax Biolabs Group Limited、Cns Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1068.71%、577.39%、289.30%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc.、Virax Biolabs Group Limited，振幅分别为42.95%、31.68%、28.57%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023213752971a1ce0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023213752971a1ce0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ONCT"],"gpt_icon":0},{"id":"2477337588","title":"Oncternal Therapeutics, Inc.盘中异动 股价大跌5.23%报1.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477337588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477337588?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:30","pubTimestamp":1729603823,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时30分，Oncternal Therapeutics, Inc.股票出现异动，股价大幅跳水5.23%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Tc Biopharm  Plc涨幅较大，Genprex, Inc.、Tc Biopharm  Plc、Ensysce Biosciences, Inc.较为活跃，换手率分别为1688.35%、1115.89%、1013.30%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Aptevo Therapeutics Inc.、Omega Therapeutics, Inc.，振幅分别为6.19%、6.07%、5.61%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221302498e3dc22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221302498e3dc22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0},{"id":"2477559865","title":"Oncternal Therapeutics, Inc.盘中异动 股价大涨7.32%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477559865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477559865?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:31","pubTimestamp":1729517471,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时31分，Oncternal Therapeutics, Inc.股票出现波动，股价大幅拉升7.32%。截至发稿，该股报1.54美元/股，成交量5434股，换手率0.18%，振幅0.00%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410212131119f53f82b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410212131119f53f82b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0},{"id":"2475990255","title":"Oncternal Therapeutics, Inc.盘中异动 急速拉升7.44%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475990255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475990255?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:36","pubTimestamp":1729085772,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时36分，Oncternal Therapeutics, Inc.股票出现波动，股价大幅上涨7.44%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213613a1e11ee2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213613a1e11ee2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0},{"id":"2474205301","title":"Oncternal Therapeutics, Inc.盘中异动 下午盘股价大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474205301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474205301?lang=zh_cn&edition=full","pubTime":"2024-10-10 03:15","pubTimestamp":1728501332,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日03时15分，Oncternal Therapeutics, Inc.股票出现异动，股价急速下挫5.32%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Inhibikase Therapeutics, Inc.、Can Fite Biopharma Ltd涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为727.56%、573.83%、250.22%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Inhibikase Therapeutics, Inc.，振幅分别为108.00%、73.66%、64.70%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101003153298e3b865&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101003153298e3b865&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ONCT","BK4139"],"gpt_icon":0},{"id":"2471386257","title":"Oncternal Therapeutics, Inc.盘中异动 股价大涨6.21%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2471386257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471386257?lang=zh_cn&edition=full","pubTime":"2024-09-30 21:53","pubTimestamp":1727704434,"startTime":"0","endTime":"0","summary":"北京时间2024年09月30日21时53分，Oncternal Therapeutics, Inc.股票出现波动，股价快速上涨6.21%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Kezar Life Sciences, Inc.、Prime Medicine, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Aditxt, Inc.、Seelos Therapeutics, Inc.、Onconetix, Inc.较为活跃，换手率分别为61.66%、25.47%、24.49%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Plus Therapeutics, Inc.，振幅分别为34.02%、32.54%、28.10%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093021535598e39d98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024093021535598e39d98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ONCT"],"gpt_icon":0},{"id":"2470873810","title":"Oncternal Therapeutics, Inc.盘中异动 早盘快速上涨6.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470873810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470873810?lang=zh_cn&edition=full","pubTime":"2024-09-27 22:20","pubTimestamp":1727446851,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日22时20分，Oncternal Therapeutics, Inc.股票出现波动，股价大幅拉升6.21%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092722205198e396af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092722205198e396af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ONCT","BK4139"],"gpt_icon":0},{"id":"2470878294","title":"Oncternal Therapeutics, Inc.盘中异动 股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470878294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470878294?lang=zh_cn&edition=full","pubTime":"2024-09-26 02:48","pubTimestamp":1727290098,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日02时48分，Oncternal Therapeutics, Inc.股票出现波动，股价急速跳水5.41%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926024819a1dc81a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926024819a1dc81a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0},{"id":"2469222731","title":"Oncternal Therapeutics, Inc.盘中异动 临近收盘股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469222731","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469222731?lang=zh_cn&edition=full","pubTime":"2024-09-24 03:52","pubTimestamp":1727121179,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日03时52分，Oncternal Therapeutics, Inc.股票出现异动，股价快速下跌5.23%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.68%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924035300a1dbf752&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924035300a1dbf752&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ONCT","BK4139"],"gpt_icon":0},{"id":"2468686307","title":"Oncternal Therapeutics, Inc.盘中异动 快速上涨6.06%报1.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468686307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468686307?lang=zh_cn&edition=full","pubTime":"2024-09-20 02:09","pubTimestamp":1726769351,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日02时09分，Oncternal Therapeutics, Inc.股票出现异动，股价急速上涨6.06%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.39%。其相关个股中，Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Edgewise Therapeutics, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃，换手率分别为5299.29%、941.61%、213.36%，振幅较大的相关个股有Exicure, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Galmed Pharmaceuticals Ltd.，振幅分别为110.91%、88.80%、78.69%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920020911a1db39c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920020911a1db39c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ONCT","BK4139"],"gpt_icon":0},{"id":"2468368530","title":"Oncternal Therapeutics, Inc.盘中异动 早盘快速下挫5.15%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468368530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468368530?lang=zh_cn&edition=full","pubTime":"2024-09-17 22:12","pubTimestamp":1726582354,"startTime":"0","endTime":"0","summary":"北京时间2024年09月17日22时12分，Oncternal Therapeutics, Inc.股票出现波动，股价快速下挫5.15%。Oncternal Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。Oncternal Therapeutics, Inc.公司简介：Oncternal Therapeutics Inc 是一家临床阶段的肿瘤公司，开发一流的新型疗法，针对广泛癌症对应的大量未满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240917221235a1dab4b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240917221235a1dab4b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ONCT","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.oncternal.com","stockEarnings":[{"period":"1week","weight":0.045},{"period":"1month","weight":-0.3181},{"period":"3month","weight":-0.7656},{"period":"6month","weight":-0.874},{"period":"1year","weight":-0.8215},{"period":"ytd","weight":-0.8918}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Oncternal Therapeutics, Inc.是一家特拉华州公司，于1997年9月24日注册成立。该公司是一家临床阶段的生物制药公司，专注于开发新型肿瘤疗法，用于治疗具有关键未满足医疗需求的癌症患者。Oncternal追求药物开发，靶向与癌症产生或进展有关的有希望但尚未开发的生物学途径，重点关注前列腺癌和血液系统恶性肿瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.55,"avgChangeRate":0.063855},{"month":2,"riseRate":0.3,"avgChangeRate":-0.022486},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.033532},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.026101},{"month":5,"riseRate":0.52381,"avgChangeRate":0.062298},{"month":6,"riseRate":0.428571,"avgChangeRate":0.011229},{"month":7,"riseRate":0.380952,"avgChangeRate":-0.041481},{"month":8,"riseRate":0.47619,"avgChangeRate":-0.035974},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.045391},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.010874},{"month":11,"riseRate":0.47619,"avgChangeRate":0.022497},{"month":12,"riseRate":0.5,"avgChangeRate":0.019072}],"exchange":"NASDAQ","name":"Oncternal Therapeutics, Inc.","nameEN":"Oncternal Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Oncternal Therapeutics, Inc.(ONCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Oncternal Therapeutics, Inc.(ONCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Oncternal Therapeutics, Inc.,ONCT,Oncternal Therapeutics, Inc.股票,Oncternal Therapeutics, Inc.股票老虎,Oncternal Therapeutics, Inc.股票老虎国际,Oncternal Therapeutics, Inc.行情,Oncternal Therapeutics, Inc.股票行情,Oncternal Therapeutics, Inc.股价,Oncternal Therapeutics, Inc.股市,Oncternal Therapeutics, Inc.股票价格,Oncternal Therapeutics, Inc.股票交易,Oncternal Therapeutics, Inc.股票购买,Oncternal Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Oncternal Therapeutics, Inc.(ONCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Oncternal Therapeutics, Inc.(ONCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}